These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4768147)

  • 1. Uterine length: a prognostic indicator for the successful use of the copper 7 intrauterine device.
    Gibor Y; Deysach L; Nissen CH
    J Reprod Med; 1973 Nov; 11(5):205-8. PubMed ID: 4768147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incrustation of marker threads of intrauterine devices in the uterine cavity and cervix uteri].
    Patai K; Berényi M; Gimes G
    Zentralbl Gynakol; 1986; 108(18):1135-9. PubMed ID: 3788342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a modified copper intrauterine device in nulliparous women with small uterine axial length.
    Goldstuck ND
    J Reprod Med; 1980 Oct; 25(4):183-6. PubMed ID: 7431367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrauterine contraception with copper-T. An investigation with attention to employment of this device among nulliparas and multiparas].
    Hansen MK; Honoré E
    Ugeskr Laeger; 1976 May; 138(19):1139-42. PubMed ID: 1265913
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Cervical and uterine perforations by copper-containing intrauterine contraceptive devices.
    Drill VA; O'Brien FB
    Am J Obstet Gynecol; 1975 Jun; 122(4):535. PubMed ID: 1146912
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical applications of the wing sound device.
    Hasson HM
    Obstet Gynecol; 1974 Apr; 43(4):498-506. PubMed ID: 4856283
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of the endometrial cavity length using Wing Sound I.
    de Castro A; Yebra C; Aznar F; Pinilla E; Nieto A; Valenzuela P; Lopez-Salva A
    Adv Contracept; 1987 Jun; 3(2):133-7. PubMed ID: 3630822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Gravigard intrauterine copper contraceptive device.
    Macourt DC
    Med J Aust; 1974 May; 1(18):717-8. PubMed ID: 4851932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of a cupro-contraceptive intrauterine device (copper 7: Gravigarde)].
    Levrier M
    Gynecologie; 1974; 25(1):35-40. PubMed ID: 4420221
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic ultrasound in the management of patients using intrauterine contraceptive devices.
    Wittmann BK; Chow TT
    Br J Obstet Gynaecol; 1976 Oct; 83(10):802-8. PubMed ID: 990221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of intra-uterine devices. Some technical considerations: II.
    Goldstuck ND
    Practitioner; 1982 Jul; 226(1369):1319-23. PubMed ID: 7111168
    [No Abstract]   [Full Text] [Related]  

  • 12. [The T spiral--A community trial of a new intrauterine device in Colombia].
    Gartner M; Calle M; Estrada A; Measham AR
    Rev Colomb Obstet Ginecol; 1974; 25(4):261-6. PubMed ID: 4469057
    [No Abstract]   [Full Text] [Related]  

  • 13. The Dalkon Shield intrauterine device.
    Med Lett Drugs Ther; 1972 Dec; 14(26):97-8. PubMed ID: 4648573
    [No Abstract]   [Full Text] [Related]  

  • 14. Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different parities.
    Canteiro R; Bahamondes MV; dos Santos Fernandes A; Espejo-Arce X; Marchi NM; Bahamondes L
    Contraception; 2010 Jun; 81(6):515-9. PubMed ID: 20472119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrauterine devices].
    Luukkainen T
    Duodecim; 1973 Oct; 89(24):1649-56. PubMed ID: 4771800
    [No Abstract]   [Full Text] [Related]  

  • 16. The wing sound. A new uterine measuring device.
    Hasson HM
    Obstet Gynecol; 1971 Jun; 37(6):915-9. PubMed ID: 4378219
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrauterine devices. Their role in family planning care.
    WHO Offset Publ; 1983; (75):1-53. PubMed ID: 6637075
    [No Abstract]   [Full Text] [Related]  

  • 18. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
    Kurz KH
    Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper intrauterine devices--a review of the literature.
    Tomlin HL; Devanesan M; Caterini H
    J Med Soc N J; 1975 May; 72(5):391-4. PubMed ID: 1094120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.